Literature DB >> 22664150

Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature.

Lisa D Hobson-Webb1, Alan D Proia, Beth L Thurberg, Suhrad Banugaria, Sean N Prater, Priya S Kishnani.   

Abstract

BACKGROUND: Late-onset Pompe disease (LOPD) is a rare cause of declining proximal muscle strength and respiratory function that can also affect other organ systems. The development of enzyme replacement therapy has made it one of the few inherited muscle disorders with treatment, but clinical response is difficult to assess due to the variable and often slow progression of illness. A better understanding of the disease's systemic effects can be gleaned through autopsy findings.
PURPOSE: The purpose of this study was to: (1) describe the histological findings observed in LOPD, (2) provide correlations between reported histological and clinical findings, and (3) review the literature on autopsy findings in LOPD.
METHODS: Histological evaluation of autopsy tissues from a 62-year-old woman with LOPD was conducted. A clinical history was obtained by review of the medical records. The literature was reviewed for previously reported histological and clinical findings in LOPD. Based on this case report and information from prior publications, histological and clinical findings for the disease were correlated.
RESULTS: Histologic examination revealed mostly mild vacuolar myopathy typical of glycogen accumulation within skeletal and smooth muscle cells. The most prominent vacuolar myopathy was in quadriceps muscle, which also exhibited chronic myositis with degenerating and regenerating muscle fibers. Transmission electron microscopy disclosed lysosomal glycogen accumulation within skeletal, cardiac, and vascular smooth muscle cells, correlating with published case reports of basilar artery and ascending aortic aneurysms and carotid artery dissection. Organs containing smooth muscle cells (the bladder, intestine, and esophagus) were also affected, explaining reports of symptoms such as urinary incontinence and dysphagia. In addition to glycogen accumulation, there was obvious damage to the contraction apparatus of myofibrils within cardiac and skeletal muscle cells. These histological and ultrastructural findings correlate with the clinical manifestations of LOPD.
CONCLUSIONS: This study is the first to describe histological findings of LOPD utilizing both traditional paraffin-processed tissues and epoxy resin embedded tissues for high-resolution light microscopy. The findings are similar to those seen in previous studies, but with improved morphological detail and glycogen preservation. This patient exhibited histological involvement of multiple organs, correlating with the clinical features of LOPD. With the advent of definitive therapy for Pompe disease, it is important to be aware of these findings and use them to develop methods for tracking therapeutic response.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22664150     DOI: 10.1016/j.ymgme.2012.05.007

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  33 in total

1.  Therapeutic advances in the management of Pompe disease and other metabolic myopathies.

Authors:  Corrado Angelini; Anna Chiara Nascimbeni; Claudio Semplicini
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

2.  Urge incontinence and gastrointestinal symptoms in adult patients with pompe disease: a cross-sectional survey.

Authors:  Nesrin Karabul; Anika Skudlarek; Janine Berndt; Cornelia Kornblum; Rudolf A Kley; Stephan Wenninger; Nikolaus Tiling; Eugen Mengel; Ursula Plöckinger; Matthias Vorgerd; Marcus Deschauer; Benedikt Schoser; Frank Hanisch
Journal:  JIMD Rep       Date:  2014-08-26

3.  Pompe disease presenting as an isolated generalized dilative arteriopathy with repeated brain and kidney infarcts.

Authors:  Véronique Quenardelle; Marc Bataillard; Dorothée Bazin; Béatrice Lannes; Valérie Wolff; Andoni Echaniz-Laguna
Journal:  J Neurol       Date:  2014-12-02       Impact factor: 4.849

4.  Postmortem Findings and Clinical Correlates in Individuals with Infantile-Onset Pompe Disease.

Authors:  Loren D M Pena; Alan D Proia; Priya S Kishnani
Journal:  JIMD Rep       Date:  2015-03-13

Review 5.  Multisystem late onset Pompe disease (LOPD): an update on clinical aspects.

Authors:  Antonio Toscano; Carmelo Rodolico; Olimpia Musumeci
Journal:  Ann Transl Med       Date:  2019-07

Review 6.  Liver depot gene therapy for Pompe disease.

Authors:  Priya S Kishnani; Dwight D Koeberl
Journal:  Ann Transl Med       Date:  2019-07

Review 7.  An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond.

Authors:  Aditi Korlimarla; Jeong-A Lim; Priya S Kishnani; Baodong Sun
Journal:  Ann Transl Med       Date:  2019-07

8.  Long term follow-up of cerebrovascular abnormalities in late onset Pompe disease (LOPD).

Authors:  Matteo Garibaldi; Sabrina Sacconi; Giovanni Antonini; Claude Desnuelle
Journal:  J Neurol       Date:  2017-01-24       Impact factor: 4.849

9.  Durable and sustained immune tolerance to ERT in Pompe disease with entrenched immune responses.

Authors:  Zoheb B Kazi; Sean N Prater; Joyce A Kobori; David Viskochil; Carrie Bailey; Renuka Gera; David W Stockton; Paul McIntosh; Amy S Rosenberg; Priya S Kishnani
Journal:  JCI Insight       Date:  2016-07-21

Review 10.  Myocardial autophagic energy stress responses--macroautophagy, mitophagy, and glycophagy.

Authors:  Lea M D Delbridge; Kimberley M Mellor; David J R Taylor; Roberta A Gottlieb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-06       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.